series-c-plus
Stage
About
Anthera was a US drug-development company focused on cardiovascular therapeutics. The company was listed on NASDAQ in 2010.
Explore Anthera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.